BACKGROUND: Falls and fall risk factors are common among people living with HIV (PLWH). We sought to identify fall risk factors among men with and without HIV. METHODS: Men aged 50-75 years with (n = 279) and without HIV (n = 379) from the Bone Strength Substudy of the Multicenter AIDS Cohort Study were included. Multinomial logistic regression models identified risk factors associated with falling. RESULTS: One hundred fourteen (41%) PLWH and 149 (39%) of uninfected men had ≥1 fall; 54 (20%) PLWH and 66 (17%) of uninfected men experienced ≥2 falls over 2 years. Five and 3% of PLWH and uninfected men, respectively, had a fall-related fracture (P = 0.34). In multivariate models, the odds of ≥2 falls were greater among men reporting illicit drug use, taking diabetes or depression medications, and with peripheral neuropathy; obesity was associated with a lower risk (all P < 0.05). In models restricted to PLWH, detectable plasma HIV-1 RNA, current use of efavirenz or diabetes medications, illicit drug use, and peripheral neuropathy were associated with greater odds of having ≥2 falls (P < 0.05). Current efavirenz use was associated with increased odds of an injurious fall; longer duration of antiretroviral therapy was protective (both P < 0.05). Greater physical activity was associated with lower risk of falls with fracture (P < 0.05). CONCLUSIONS: Identified risk factors for recurrent falls or fall with fracture included low physical activity, detectable HIV-1 RNA, use of efavirenz, or use of medications to treat diabetes and depression. Fall risk reduction should prioritize interventions targeting modifiable risk factors including increased physical activity, antiretroviral therapy adherence, and transition off efavirenz.
BACKGROUND: Falls and fall risk factors are common among people living with HIV (PLWH). We sought to identify fall risk factors among men with and without HIV. METHODS:Men aged 50-75 years with (n = 279) and without HIV (n = 379) from the Bone Strength Substudy of the Multicenter AIDS Cohort Study were included. Multinomial logistic regression models identified risk factors associated with falling. RESULTS: One hundred fourteen (41%) PLWH and 149 (39%) of uninfected men had ≥1 fall; 54 (20%) PLWH and 66 (17%) of uninfected men experienced ≥2 falls over 2 years. Five and 3% of PLWH and uninfected men, respectively, had a fall-related fracture (P = 0.34). In multivariate models, the odds of ≥2 falls were greater among men reporting illicit drug use, taking diabetes or depression medications, and with peripheral neuropathy; obesity was associated with a lower risk (all P < 0.05). In models restricted to PLWH, detectable plasma HIV-1 RNA, current use of efavirenz or diabetes medications, illicit drug use, and peripheral neuropathy were associated with greater odds of having ≥2 falls (P < 0.05). Current efavirenz use was associated with increased odds of an injurious fall; longer duration of antiretroviral therapy was protective (both P < 0.05). Greater physical activity was associated with lower risk of falls with fracture (P < 0.05). CONCLUSIONS: Identified risk factors for recurrent falls or fall with fracture included low physical activity, detectable HIV-1 RNA, use of efavirenz, or use of medications to treat diabetes and depression. Fall risk reduction should prioritize interventions targeting modifiable risk factors including increased physical activity, antiretroviral therapy adherence, and transition off efavirenz.
Authors: Ned Sacktor; Richard L Skolasky; Christopher Cox; Ola Selnes; James T Becker; Bruce Cohen; Eileen Martin; Eric N Miller Journal: J Neurovirol Date: 2010-10 Impact factor: 2.643
Authors: Karen L Margolis; Lisa Palermo; Eric Vittinghoff; Gregory W Evans; Hal H Atkinson; Bruce P Hamilton; Robert G Josse; Patrick J O'Connor; Debra L Simmons; Margaret Tiktin; Ann V Schwartz Journal: J Gen Intern Med Date: 2014-08-16 Impact factor: 5.128
Authors: Anjali Sharma; Donald R Hoover; Qiuhu Shi; Susan Holman; Michael W Plankey; Amber L Wheeler; Kathleen Weber; Michelle Floris-Moore; Hector H Bolivar; David E Vance; Wendy J Mack; Elizabeth T Golub; Marcia McDonnell Holstad; Michael T Yin Journal: Antivir Ther Date: 2016-07-18
Authors: Ruibin Wang; Sabina A Haberlen; Frank J Palella; Michael J Mugavero; Joseph B Margolick; Bernard J C Macatangay; Otoniel Martínez-Maza; Lisa P Jacobson; Alison G Abraham Journal: AIDS Date: 2018-11-13 Impact factor: 4.177
Authors: Ian R McNicholl; Monica Gandhi; C Bradley Hare; Meredith Greene; Edgar Pierluissi Journal: Pharmacotherapy Date: 2017-11-30 Impact factor: 4.705
Authors: Anjali Sharma; Donald R Hoover; Qiuhu Shi; Susan Holman; Michael W Plankey; Phyllis C Tien; Kathleen M Weber; Michelle Floris-Moore; Hector H Bolivar; David E Vance; Elizabeth T Golub; Marcia McDonnell Holstad; Michael T Yin Journal: Antivir Ther Date: 2018 Impact factor: 1.679
Authors: Julie A Womack; Terrence E Murphy; Linda Leo-Summers; Jonathan Bates; Samah Jarad; Alexandria C Smith; Thomas M Gill; Evelyn Hsieh; Maria C Rodriguez-Barradas; Phyllis C Tien; Michael T Yin; Cynthia A Brandt; Amy C Justice Journal: J Acquir Immune Defic Syndr Date: 2022-10-01 Impact factor: 3.771
Authors: Mona Abdo; Xingye Wu; Anjali Sharma; Katherine K Tassiopoulos; Todd T Brown; Susan L Koletar; Michael T Yin; Kristine M Erlandson Journal: AIDS Res Hum Retroviruses Date: 2022-02-02 Impact factor: 1.723
Authors: Kristine M Erlandson; Thomas G Travison; Hao Zhu; Jay Magaziner; Rosaly Correa-de-Araujo; Peggy M Cawthon; Shalender Bhasin; Todd Manini; Roger A Fielding; Frank J Palella; Lawrence Kingsley; Jordan E Lake; Anjali Sharma; Phyllis C Tien; Kathleen M Weber; Michael T Yin; Todd T Brown Journal: J Gerontol A Biol Sci Med Sci Date: 2020-06-18 Impact factor: 6.053
Authors: Julie A Womack; Terrence E Murphy; Christine Ramsey; Harini Bathulapalli; Linda Leo-Summers; Alexandria C Smith; Jonathan Bates; Samah Jarad; Thomas M Gill; Evelyn Hsieh; Maria C Rodriguez-Barradas; Phyllis C Tien; Michael T Yin; Cynthia Brandt; Amy C Justice Journal: J Acquir Immune Defic Syndr Date: 2021-10-01 Impact factor: 3.771
Authors: Christina K Psomas; Donald R Hoover; Qiuhu Shi; Todd T Brown; David E Vance; Susan Holman; Michael W Plankey; Phyllis C Tien; Kathleen M Weber; Michelle Floris-Moore; Hector H Bolivar; Elizabeth T Golub; Marcia McDonnell Holstad; Kendra K Radtke; Bani Tamraz; Kristine M Erlandson; Leah H Rubin; Anjali Sharma Journal: J Acquir Immune Defic Syndr Date: 2022-07-01 Impact factor: 3.771
Authors: Rafael Antonius Araujo; Sávio Amaral; Arthur Tolentino; Diana Zeballos; Iris Montaño; Lucca S Souza; Liliane Lins-Kusterer; Carlos Brites Journal: AIDS Behav Date: 2021-07-26